Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Vitamin D3 in Pediatric Sickle Cell Disease
NCT06274203Completed
- Sponsor
- Zagazig University
- Start
- May 2023
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Open-label, single-arm trial of vitamin d in Vitamin D deficiency (VDD), sponsored by Zagazig University. Primary endpoint: Serum 25-hydroxyvitamin D level at 6 months. Started May 2023; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT06274203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06274203.